Ticker Hub
INAB — AI Analysis & Sentiment
3 recent AI-generated analyses for INAB. Sentiment and confidence insights updated continuously.
IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026
IN8bio's positive clinical data for glioblastoma therapy marks a significant advancement in treating a deadly cancer, potentially unlocking substan...
Jun 1, 2026IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma
IN8bio's new translational data offers a mechanistic understanding of their glioblastoma therapy, showing immune system remodeling linked to improv...
May 14, 2026IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
IN8bio's recent financial and clinical updates significantly strengthen its outlook, reducing operational risks and highlighting the potential of i...
Mar 12, 2026